13,776 Shares in CME Group Inc. $CME Purchased by Callan Family Office LLC

Callan Family Office LLC acquired a new position in CME Group Inc. (NASDAQ:CME - Free Report) in the second quarter, according to the company in its most recent filing with the SEC. The firm acquired 13,776 shares of the financial services provider's stock, valued at approximately $3,042,000.

Several other institutional investors also recently modified their holdings of the company. Whipplewood Advisors LLC raised its stake in shares of CME Group by 2,075.0% in the first quarter. Whipplewood Advisors LLC now owns 87 shares of the financial services provider's stock valued at $26,000 after purchasing an additional 83 shares in the last quarter. Elkhorn Partners Limited Partnership acquired a new stake in CME Group during the fourth quarter worth $27,000. Hilton Head Capital Partners LLC acquired a new stake in CME Group during the fourth quarter worth $28,000. Mowery & Schoenfeld Wealth Management LLC bought a new stake in CME Group in the 2nd quarter valued at $28,000. Finally, Legacy Wealth Managment LLC ID increased its holdings in CME Group by 191.9% in the 4th quarter. Legacy Wealth Managment LLC ID now owns 108 shares of the financial services provider's stock valued at $29,000 after buying an additional 71 shares during the period. Institutional investors and hedge funds own 87.75% of the company's stock.

Insider Transactions at CME Group

In other news, Director William R. Shepard purchased 325 shares of the business's stock in a transaction that occurred on Thursday, June 25th. The stock was purchased at an average cost of $230.57 per share, with a total value of $74,935.25. Following the acquisition, the director directly owned 260,442 shares of the company's stock, valued at approximately $60,050,111.94. This trade represents a 0.12% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. 0.30% of the stock is owned by corporate insiders.

CME Group Stock Performance

CME Group stock opened at $274.98 on Friday. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02. The stock has a fifty day moving average price of $251.17 and a two-hundred day moving average price of $279.65. CME Group Inc. has a 52-week low of $218.31 and a 52-week high of $329.16. The firm has a market capitalization of $98.88 billion, a P/E ratio of 23.32, a P/E/G ratio of 3.20 and a beta of 0.23.

CME Group (NASDAQ:CME - Get Free Report) last issued its quarterly earnings data on Wednesday, July 22nd. The financial services provider reported $2.99 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.91 by $0.08. CME Group had a return on equity of 15.60% and a net margin of 63.30%.The company had revenue of $1.71 billion during the quarter, compared to analysts' expectations of $1.68 billion. During the same period last year, the business earned $2.96 earnings per share. The business's revenue was up .8% on a year-over-year basis. As a group, analysts anticipate that CME Group Inc. will post 12.27 EPS for the current fiscal year.

CME Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, September 25th. Investors of record on Wednesday, September 9th will be issued a dividend of $1.30 per share. This represents a $5.20 annualized dividend and a yield of 1.9%. The ex-dividend date of this dividend is Wednesday, September 9th. CME Group's dividend payout ratio (DPR) is currently 44.11%.

Analyst Ratings Changes

A number of equities analysts have recently issued reports on CME shares. The Goldman Sachs Group dropped their price objective on shares of CME Group from $267.00 to $245.00 and set a "sell" rating for the company in a research note on Tuesday, June 30th. Barclays decreased their target price on shares of CME Group from $316.00 to $270.00 and set an "equal weight" rating on the stock in a research report on Thursday, July 9th. Raymond James Financial reissued an "outperform" rating and issued a $320.00 target price on shares of CME Group in a research note on Thursday, July 2nd. Morgan Stanley increased their price target on shares of CME Group from $324.00 to $330.00 and gave the stock an "overweight" rating in a research report on Thursday, July 23rd. Finally, Keefe, Bruyette & Woods raised CME Group from a "market perform" rating to an "outperform" rating and set a $305.00 price objective on the stock in a report on Thursday, June 18th. Nine equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and three have assigned a Sell rating to the company's stock. Based on data from MarketBeat, CME Group currently has an average rating of "Hold" and an average price target of $288.56.

CME Group Profile

CME Group Inc is a global markets company that operates some of the world's largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company's core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source